https://www.cancer.gov/about-cancer/treatment/drugs/tisotumabvedotin-tftv
Tisotumab Vedotin-tftv - NCI
Tisotumab vedotin is a type of drug called an antibody-drug conjugate. Antibody-drug conjugates consist of a monoclonal antibody chemically linked to a...
tisotumab vedotinnci
https://pubmed.ncbi.nlm.nih.gov/31796521/
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer
Tisotumab vedotin demonstrated a manageable safety profile and encouraging antitumor activity in patients with previously treated recurrent or metastatic...
tisotumab vedotinpreviouslytreatedrecurrentmetastatic
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tisotumab-vedotin
Definition of tisotumab vedotin - NCI Dictionary of Cancer Terms - NCI
NCI's Dictionary of Cancer Terms provides easy-to-understand definitions for words and phrases related to cancer and medicine.
definition oftisotumab vedotinncidictionarycancer
https://www.mayoclinic.org/drugs-supplements/tisotumab-vedotin-tftv-intravenous-route/description/drg-20554244
Tisotumab vedotin-tftv (intravenous route) - Side effects & uses - Mayo Clinic
tisotumab vedotinside effectsintravenousrouteuses
https://www.nice.org.uk/guidance/indevelopment/gid-ta10620/documents
Project documents | Tisotumab vedotin for treating recurrent or metastatic cervical cancer that has...
Tisotumab vedotin for treating recurrent or metastatic cervical cancer that has progressed on or after systemic treatment [ID3753]